HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marieta Xagorari Selected Research

PVDA protocol

11/2018BCL2L12 improves risk stratification and prediction of BFM-chemotherapy response in childhood acute lymphoblastic leukemia.
7/2018Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
9/2017miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marieta Xagorari Research Topics

Disease

4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2021 - 09/2017
1COVID-19
08/2021
1Insulin Resistance
01/2016
1Hyperinsulinism (Hyperinsulinemia)
01/2016

Drug/Important Bio-Agent (IBA)

1GlucocorticoidsIBA
12/2021
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
12/2021
1WastewaterIBA
08/2021
1DNA (Deoxyribonucleic Acid)IBA
08/2021
1RNA (Ribonucleic Acid)IBA
07/2018
1Biomarkers (Surrogate Marker)IBA
01/2016
1Arginine Vasopressin (Argipressin)IBA
01/2016

Therapy/Procedure

3PVDA protocol
11/2018 - 09/2017
2Therapeutics
12/2021 - 07/2018
1Drug Therapy (Chemotherapy)
11/2018